{
    "title": "Shares down for troubled GlaxoSmithKline after sickly sales outlook",
    "url": "https://www.dailymail.co.uk/money/markets/article-2703275/Shares-troubed-GlaxoSmithKline-sickly-sales-outlook.html",
    "date": "2014-07-23",
    "keywords": [
        "company",
        "cent",
        "year",
        "glaxosmithkline",
        "competition",
        "china",
        "growth",
        "share",
        "scandal",
        "track",
        "trading",
        "prosecution",
        "gsk",
        "outlook",
        "mail",
        "gmt",
        "july",
        "email",
        "view",
        "bluechip",
        "faller",
        "drugmaker",
        "group",
        "half",
        "corruption",
        "operating",
        "profit",
        "period",
        "executive",
        "sir",
        "government",
        "advisor",
        "centalistair",
        "analyst",
        "investment",
        "bank",
        "berenberg",
        "disappointment",
        "downgrade",
        "power",
        "portfolio",
        "market",
        "footsie",
        "price",
        "fee",
        "charge",
        "healthcare",
        "medicinesin",
        "bribery",
        "boss",
        "mark",
        "country",
        "giant",
        "antibribery",
        "revealedwitty",
        "business",
        "contrary",
        "tolerance",
        "kind",
        "behaviour",
        "staff",
        "majority",
        "size",
        "potential",
        "anticorruption",
        "place",
        "blame",
        "rogue",
        "drug",
        "patent",
        "cliff",
        "protection",
        "money",
        "research",
        "development",
        "witty",
        "asthma",
        "treatment",
        "performance",
        "sale",
        "europe",
        "environmentthe",
        "dividend"
    ],
    "category": [
        "money",
        "markets"
    ]
}